Ken Griffin
VOR icon

Ken Griffin’s Vor Biopharma VOR Stock Holding History

Ken Griffin’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.65M Sell
148,768
-285,126
-66% -$4.02M ﹤0.01% 5503
2025
Q4 		$5.68M Buy
433,894
+428,208
+7,531% +$7.97M ﹤0.01% 4090
2025
Q3 		$277K Buy
+5,686
New +$229K ﹤0.01% 10553
2025
Q1 		– Sell
-10,020
Closed -$222K – 15650
2024
Q4 		$222K Buy
10,020
+9,984
+27,733% +$165K ﹤0.01% 10252
2024
Q3 		$499 Sell
36
-4,196
-99% -$76.5K ﹤0.01% 14009
2024
Q2 		$84.6K Buy
4,232
+1,978
+88% +$64K ﹤0.01% 11141
2024
Q1 		$107K Buy
2,254
+722
+47% +$31.7K ﹤0.01% 11264
2023
Q4 		$69K Buy
1,532
+1,451
+1,791% +$59.9K ﹤0.01% 11403
2023
Q3 		$3.41K Sell
81
-599
-88% -$32.5K ﹤0.01% 13588
2023
Q2 		$42K Buy
680
+6
+0.9% +$548 ﹤0.01% 12020
2023
Q1 		$72.5K Sell
674
-747
-53% -$82.8K ﹤0.01% 11683
2022
Q4 		$189K Buy
1,421
+301
+27% +$29.8K ﹤0.01% 10229
2022
Q3 		$89K Sell
1,120
-2,849
-72% -$280K ﹤0.01% 11184
2022
Q2 		$394K Buy
3,969
+1,089
+38% +$111K ﹤0.01% 9170
2022
Q1 		$348K Buy
2,880
+1,635
+131% +$278K ﹤0.01% 10250
2021
Q4 		$289K Buy
+1,245
New +$359K ﹤0.01% 11009

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ken Griffin's VOR Position: Q1 2026 in Review

Ken Griffin reduced its Vor Biopharma (VOR) stake by 66% in Q1 2026, selling an estimated $4.02M and leaving 148,768 shares worth $2.65M. The position accounts for ﹤0.01% of the portfolio, ranked #5503.

Ken Griffin first reported a position in VOR in Q4 2021 and has held it in 16 quarters since. The position peaked at $5.68M in Q4 2025. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

  • Ken Griffin held 148,768 shares of Vor Biopharma worth $2.65M as of Q1 2026.
  • Ken Griffin sold 285,126 Vor Biopharma shares in Q1 2026, an estimated $4.02M.
  • Vor Biopharma made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #5503 holding.
  • Ken Griffin first reported a position in Vor Biopharma in Q4 2021 and has held it in 16 quarters since.
  • Ken Griffin's Vor Biopharma position peaked at $5.68M in Q4 2025.
  • 80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.